Altace is an angiotensin converting enzyme inhibitor, or ACE-inhibitor, used in the treatment of hypertension or high blood pressure. RxList.com reports it is recommended for individuals over the age of 55 with a history of stroke, peripheral vascular disease, coronary artery disease and diabetes. As of 2010, the patent has expired on Altace and generic alternatives are available.
Ramipril
Ramipril, as the generic option for the brand Altace, is used to treat high blood pressure. According to RxList.com, it is available in strengths of 10 mg, 5 mg, 2.5 mg and 1.25 mg tablets and capsules. Ramipril, as of 2010, is manufactured by various pharmaceutical companies including Apotex Corporation, Lupin Pharmaceuticals Inc. and Roxane Laboratories Inc.
Prescribing Ramipril
The U.S. Food and Drug Administration assures that ramipril is the bioequivalent of Altace, which means that the therapeutic effects are the same. Prescriptions are required for dispensing ramipril as with any other prescription medication.
Generic Criteria
According to the FDA, ramipril is required to maintain the same quality and standards as the brand Altace. Dosage and effectiveness do not differ. Appearance may vary with each manufacturer, but the therapeutic properties are the same. This protects the public against variations in its chemical composition that would be potentially harmful. The Federal Trade Commission states that generic drugs cost 30 to 80 percent less than brand names, resulting in significant savings to the public.
